Israel’s Teva Lifts Outlook With War Not Curbing Drug Production

Novartis Spinoff Sandoz to Start Trading as Standalone Drugmaker

Berlusconi Office Backing $100 Million Pharma Startup Qualifyze

Gilead Recovers as Quarterly Revenue Reassures Investors

Private Equity Backers of Plan B Morning-After Pill Weigh $4 Billion Sale of Company

Roivant Attracts Interest for $7 Billion-Plus Bowel Drug

Teva Weighs Sale of $2 Billion Active Ingredients Unit

Teva Plans to Cut Back Generic Drug Production Even As Shortages Intensify

White House Assembles Secret Team to Tackle Drug Shortages, Quality Woes